Home Determination of resveratrol in nanoformulations using UV-spectroscopy: forced degradation and drug entrapment
Article
Licensed
Unlicensed Requires Authentication

Determination of resveratrol in nanoformulations using UV-spectroscopy: forced degradation and drug entrapment

  • Bhavna Sonule

    Miss Bhavna Sonule pursuing her M.S. (Pharm.) in Pharmaceutics from National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India. She is now in her final semester and will be completing her master’s in June 2024. Her area of research work is novel drug delivery systems especially drug targeting to the breast tumor.

    , Nikhil Mehetre

    Mr Nikhil Mehetre pursuing his M.S. (Pharm.) in Pharmaceutics from National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India. He is now in his final semester and will be completing his master’s in June 2024. His area of research work is drug targeting in the brain.

    and Lalit Kumar

    Dr. Lalit Kumar obtained his PhD in Pharmaceutical Sciences from Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India in 2016. He has 2 Indian patents, filed 6 patents, published 2 books, published more than 30 book chapters and around 120 articles in peer reviewed journals. He has about 15 years of teaching and research experience. His work includes novel drug delivery systems (especially nanoformulations), analytical methods development, and QbD. He has successfully completed more than ten research projects funded by the AICTE, New Delhi, Karnataka state VGST, Bengaluru, ICMR, New Delhi, SERB, New Delhi. Presently, he is an Assistant Professor in the Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India.

    EMAIL logo
Published/Copyright: June 6, 2024
Become an author with De Gruyter Brill

Abstract

Dietary polyphenols from plant sources play an important role in the human diet. They have various biological effects, such as protein kinase inhibition, antibacterial, anticancer, antiulcer, antiarthritic, and anti-angiogenic properties. Among the various phenolic chemicals found in plants, resveratrol (trans-3,5,4′-trihydroxystilbene) (RVT) is a non-flavonoid polyphenolic compound that has been extensively studied for its health-promoting advantages, including its anti-cancer, neuroprotective, anti-inflammatory, antioxidant, and cardio-protective activities. Considering its potential in pharmaceutical nanoformulations, a rapid, economical, sensitive, and robust UV spectrophotometric method was developed and validated. The proposed method was developed in phosphate buffer at pH 7.4 to estimate the RVT content in the pharmaceutical nanoformulation. The method was developed at a reported wavelength of 306 nm. The developed method was validated according to ICH Q2A (R1) guidelines and was applied for the estimation of RVT in prepared nanoformulations. The method showed exceptional linearity in the range of (1–6) μg mL−1 with a coefficient of determinant value of 0.9998. The study proves that the developed method is linear, precise, sensitive, robust, reproducible, and accurate. This method can be applied for the estimation of RVT in nanoformulations and other bulk dosage forms.


Corresponding author: Lalit Kumar, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hajipur 844 102, Vaishali, Bihar, India, E-mail:

About the authors

Bhavna Sonule

Miss Bhavna Sonule pursuing her M.S. (Pharm.) in Pharmaceutics from National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India. She is now in her final semester and will be completing her master’s in June 2024. Her area of research work is novel drug delivery systems especially drug targeting to the breast tumor.

Nikhil Mehetre

Mr Nikhil Mehetre pursuing his M.S. (Pharm.) in Pharmaceutics from National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India. He is now in his final semester and will be completing his master’s in June 2024. His area of research work is drug targeting in the brain.

Lalit Kumar

Dr. Lalit Kumar obtained his PhD in Pharmaceutical Sciences from Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India in 2016. He has 2 Indian patents, filed 6 patents, published 2 books, published more than 30 book chapters and around 120 articles in peer reviewed journals. He has about 15 years of teaching and research experience. His work includes novel drug delivery systems (especially nanoformulations), analytical methods development, and QbD. He has successfully completed more than ten research projects funded by the AICTE, New Delhi, Karnataka state VGST, Bengaluru, ICMR, New Delhi, SERB, New Delhi. Presently, he is an Assistant Professor in the Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India.

Acknowledgments

The authors are thankful to National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, Vaishali, Bihar, India, for providing all the necessary facilities to complete this work.

  1. Research ethics: Not applicable.

  2. Author contributions: Bhavna Sonule: Literature search, data collection, analysis or interpretation, manuscript writing; Nikhil Mehetre: Data collection or processing, analysis or interpretation; Lalit Kumar: Conceptualization, concept, design, writing-review and editing, supervision, resources.

  3. Competing interests: The authors state no conflict of interest.

  4. Research funding: None declared.

  5. Data availability: The raw data may be obtained on request basis.

References

1. Quideau, S.; Deffieux, D.; Douat‐Casassus, C.; Pouységu, L. Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis. Angew. Chem., Int. Ed. 2011, 50 (3), 586–621; https://doi.org/10.1002/anie.201000044.Search in Google Scholar PubMed

2. Sulaiman, C. T.; Balachandran, I. Total Phenolics and Total Flavonoids in Selected Indian Medicinal Plants. Indian J. Pharm. Sci. 2012, 74 (3), 258; https://doi.org/10.4103/0250-474x.106069.Search in Google Scholar

3. Khandagale, T. T.; Singh, K.; Sinha, S.; Puri, A. In Silico Study of Phytochemicals for Anticholinesterase Activity as a Potential Drug Target Against Alzheimer’s Disease. Chem. Biol. Lett. 2022, 9 (2), 310.Search in Google Scholar

4. Dabur, R.; Sharma, B.; Mittal, A. Mechanistic Approach of Anti-Diabetic Compounds Identified from Natural Sources. Chem. Biol. Lett. 2018, 5 (2), 63–99.Search in Google Scholar

5. Yang, B.; Dong, Y.; Wang, F.; Zhang, Y. Nanoformulations to Enhance the Bioavailability and Physiological Functions of Polyphenols. Molecules 2020, 25 (20), 4613; https://doi.org/10.3390/molecules25204613.Search in Google Scholar PubMed PubMed Central

6. Murugesan, N.; Damodaran, C.; Krishnamoorthy, S. Niosomal Formulation of Quercetin and Resveratrol and In vitro Release Studies. J. Integr. Sci. Technol. 2022, 10 (2), 134–138.Search in Google Scholar

7. Novelle, M. G.; Wahl, D.; Diéguez, C.; Bernier, M.; De Cabo, R. Resveratrol Supplementation: Where Are We Now and where Should We Go? Ageing Res. Rev. 2015, 21, 1–15; https://doi.org/10.1016/j.arr.2015.01.002.Search in Google Scholar PubMed PubMed Central

8. Wolter, F.; Stein, J. Biological Activities of Resveratrol and Its Analogs. Drugs Fut. 2002, 27 (10), 949–959.10.1358/dof.2002.027.10.856987Search in Google Scholar

9. Baur, J. A.; Sinclair, D. A. Therapeutic Potential of Resveratrol: The in vivo Evidence. Nat. Rev. Drug Discovery 2006, 5 (6), 493–506; https://doi.org/10.1038/nrd2060.Search in Google Scholar PubMed

10. Juan, M. E.; Lamuela-Raventos, R. M.; de la Torre-Boronat, M. C.; Planas, J. M. Determination of Trans-Resveratrol in Plasma by HPLC. Anal. Chem. 1999, 71 (3), 747–750; https://doi.org/10.1021/ac9808831.Search in Google Scholar PubMed

11. Cvetković, Ž. S.; Nikolić, V. D.; Savić, I. M.; Savić-Gajić, I. M.; Nikolić, L. B. Development and Validation of an RP-HPLC Method for Quantification of Trans-Resveratrol in the Plant Extracts. Hem. Ind. 2015, 69 (6), 679–687; https://doi.org/10.2298/hemind140917004c.Search in Google Scholar

12. Jagwani, S.; Jalalpure, S.; Dhamecha, D.; Hua, G. S.; Jadhav, K. A Stability Indicating Reversed Phase HPLC Method for Estimation of Trans-Resveratrol in Oral Capsules and Nanoliposomes. Anal. Chem. Lett. 2019, 9, 711–726; https://doi.org/10.1080/22297928.2019.1696227.Search in Google Scholar

13. Singh, G.; Pai, R. S. A Rapid Reversed-phase HPLC Method for Analysis of Trans-resveratrol in PLGA Nanoparticulate Formulation. Int. Scholarly Res. Not. 2014, 2014, 248635; https://doi.org/10.1155/2014/248635.Search in Google Scholar

14. Kumar, S.; Lather, V.; Pandita, D. Stability Indicating Simplified HPLC Method for Simultaneous Analysis of Resveratrol and Quercetin in Nanoparticles and Human Plasma. Food Chem. 2016, 197 (Pt A), 959–964; https://doi.org/10.1016/j.foodchem.2015.11.078.Search in Google Scholar PubMed

15. Kurangi, B.; Jalalpure, S.; Jagwani, S. A Validated Stability-Indicating HPLC Method for Simultaneous Estimation of Resveratrol and Piperine in Cubosome and Human Plasma. J. Chromatography B 2019, 1122–1123, 39-48.10.1016/j.jchromb.2019.05.017Search in Google Scholar PubMed

16. Gadag, S.; Narayan, R.; Mehta, C. H.; Suresh, A.; Nayak, U. Y. Development and Validation of a Rapid and Sensitive Stability-Indicating RP-HPLC Method for Resveratrol Quantification in Pharmaceutical Formulation. Ind. J. Pharm. Edu. Res. 2021, 55 (3s), S825–S836; https://doi.org/10.5530/ijper.55.3s.190.Search in Google Scholar

17. Chen, X.; He, H.; Wang, G.; Yang, B.; Ren, W.; Ma, L.; Yu, Q. Stereospecific Determination of Cis‐and Trans‐Resveratrol in Rat Plasma by HPLC: Application to Pharmacokinetic Studies. Biomed. Chromatogr. 2007, 21 (3), 257–265; https://doi.org/10.1002/bmc.747.Search in Google Scholar PubMed

18. Singh, G.; Pai, R. S.; Pandit, V. In vivo Pharmacokinetic Applicability of a Simple and Validated HPLC Method for Orally Administered Trans-resveratrol Loaded Polymeric Nanoparticles to Rats. J. Pharm. Invest. 2014, 44, 69–78; https://doi.org/10.1007/s40005-013-0105-0.Search in Google Scholar

19. Mittal, S.; Ali, J.; Baboota, S. DoE Engineered Development and Validation of an RP-HPLC Method for Simultaneous Estimation of Temozolomide and Resveratrol in Nanostructured Lipid Carrier. J. AOAC Int. 2022, 105 (5), 1258–1267; https://doi.org/10.1093/jaoacint/qsac045.Search in Google Scholar PubMed

20. Validation of Analytical Procedures: Text and Methodology Q2(R1). ICH Harmonized Tripartite Guidelines. Guidelines Developed by ICH Expert Working Group, 2005. Available at: https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf (accessed 2024-05-27).Search in Google Scholar

21. Douglas, E. V. P.; Blundel, T. L.; Ascher, D. B. pkCSM: Predicting Small-Molecule Pharmacokinetic Properties Using Graph-Based Signatures. J. Med. Chem. 2015, 58 (9), 4066–4072, https://doi.org/10.1021/acs.jmedchem.5b00104.Search in Google Scholar PubMed PubMed Central

22. Bhaskaran, N. A.; Kumar, L.; Reddy, M. S.; Pai, K. G. An Analytical “Quality by Design” Approach in RP-HPLC Method Development and Validation for Reliable and Rapid Estimation of Irinotecan in an Injectable Formulation. Acta Pharm. 2021, 71 (1), 57–79; https://doi.org/10.2478/acph-2021-0008.Search in Google Scholar PubMed

23. Vaz, V. M.; Jitta, S. R.; Verma, R.; Kumar, L. Hesperetin Loaded Proposomal Gel for Topical Antioxidant Activity. J. Drug Delivery Sci. Technol. 2021, 66, 102873; https://doi.org/10.1016/j.jddst.2021.102873.Search in Google Scholar

24. Pires, D.; Blundell, T. L.; Ascher, D. B. PkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 2015, 58 (9), 4066–4072; https://doi.org/10.1021/acs.jmedchem.5b00104.Search in Google Scholar

25. Sharkawi, M. M. Z.; Safwat, M. T.; Abdelaleem, E. A.; Abdelwahab, N. S. Chromatographic Analysis of Triple Cough Therapy; Bromhexine, Guaiafenesin and Salbutamol and Pharmaceutical Impurity: In-Silico Toxicity Profile of Drug Impurity. BMC Chem. 2024, 18 (1), 19; https://doi.org/10.1186/s13065-024-01122-5.Search in Google Scholar PubMed PubMed Central

Received: 2024-03-27
Accepted: 2024-05-21
Published Online: 2024-06-06
Published in Print: 2024-07-26

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/tsd-2024-2595/html
Scroll to top button